Literature DB >> 11486906

Massive 5-oxoprolinuria with normal 5-oxoprolinase and glutathione synthetase activities.

E Riudor1, J A Arranz, R Alvarez, K Carlsson, M del Toro, F Salmerón, F Piñol, E Ristoff, M Sentis, A Larsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11486906     DOI： 10.1023/a:1010569021839

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  5 in total

1.  Transient 5-oxoprolinuria in a very low-birthweight infant.

Authors:  A Goto; A Ishida; R Goto; K Hayasaka; K Nanao; A Yamashita; S Yamaguchi; G Takada
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Quantitative analysis of urinary pyroglutamic acid in patients with hyperammonemia.

Authors:  T Nakanishi; A Shimizu; K Saiki; F Fujiwara; S Funahashi; A Hayashi
Journal:  Clin Chim Acta       Date:  1991-03-29       Impact factor: 3.786

3.  Urinary excretion of 5-L-oxoproline (pyroglutamic acid) during early life in term and preterm infants.

Authors:  A A Jackson; C Persaud; M Hall; S Smith; N Evans; N Rutter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-05       Impact factor: 5.747

4.  5-Oxoprolinuria in patients with and without defects in the gamma-glutamyl cycle.

Authors:  E Mayatepek
Journal:  Eur J Pediatr       Date:  1999-03       Impact factor: 3.183

5.  Growth failure, encephalopathy, and endocrine dysfunctions in two siblings, one with 5-oxoprolinase deficiency.

Authors:  L H Cohen; E Vamos; C Heinrichs; M Toppet; W Courtens; A Kumps; Y Mardens; B Carlsson; L Grillner; A Larsson
Journal:  Eur J Pediatr       Date:  1997-12       Impact factor: 3.183
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.